Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Prostate Testing for Cancer an...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

Bibliographic Details
Main Authors: J. Donovan, F. Hamdy, D. Neal, T. Peters, S. Oliver, L. Brindle, D. Jewell, P. Powell, D. Gillatt, D. Dedman, N. Mills, M. Smith, S. Noble, A. Lane, ProtecT Study Group
Format: Article
Language:English
Published: NIHR Journals Library 2003-01-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta7140
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.3310/hta7140

Similar Items

  • Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
    by: Donovan, J, et al.
    Published: (2003)
  • Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial
    by: Johnston, T, et al.
    Published: (2016)
  • Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
    by: S. Sanghera, et al.
    Published: (2020-10-01)
  • A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
    by: Donovan, JL, et al.
    Published: (2017)
  • Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
    by: Rosario, D, et al.
    Published: (2008)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs